{"id":3372,"date":"2023-12-07T12:21:18","date_gmt":"2023-12-07T11:21:18","guid":{"rendered":"https:\/\/www.celltrend.de\/?p=3372"},"modified":"2024-01-09T12:38:47","modified_gmt":"2024-01-09T11:38:47","slug":"new-study-about-severity-of-long-covid-symptoms-and-their-correlation-with-the-increased-level-of-autoantibodies-was-published","status":"publish","type":"post","link":"https:\/\/www.celltrend.de\/en\/new-study-about-severity-of-long-covid-symptoms-and-their-correlation-with-the-increased-level-of-autoantibodies-was-published\/","title":{"rendered":"New study about severity of Long-COVID symptoms and their correlation with the increased level of autoantibodies was published"},"content":{"rendered":"<p style=\"text-align: center;\">A new study about severity of neurological Long-COVID symptoms and their correlation with the increased level of autoantibodies was published. In Table 1 you can have a look at the 200 individuals which were recruited and put into 3 groups. One group with 72 patients were diagnosed with Long-COVID, second group with 58 patients had been infected by SARS-CoV-2 without persisting symptoms (COVID) and the third group is a control group with 70 patients (No COVID).<\/p>\n<p style=\"text-align: center;\">The results of this study showed that the concentrations of evaluated autoantibodies (Angiotensin-1, Beta-1, Beta-2, Endothelin, Muscarinergic Choline Receptor 3 and 4) were significant higher in the Long-COVID group. Furthermore the concentrations of the autoantibodies correlates to the intensity of neurological disorders like fatigue and attention.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-3369 size-full\" src=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-200-Teilnehmer.png\" alt=\"\" width=\"319\" height=\"372\" srcset=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-200-Teilnehmer.png 319w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-200-Teilnehmer-257x300.png 257w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-200-Teilnehmer-129x150.png 129w\" sizes=\"auto, (max-width: 319px) 100vw, 319px\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3367 aligncenter\" src=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-3-Gruppen.png\" alt=\"\" width=\"746\" height=\"197\" srcset=\"https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-3-Gruppen.png 746w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-3-Gruppen-300x79.png 300w, https:\/\/www.celltrend.de\/wp-content\/uploads\/2023\/12\/Studie-3-Gruppen-150x40.png 150w\" sizes=\"auto, (max-width: 746px) 100vw, 746px\" \/><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1568997223001799?via%3Dihub\">Here <\/a> you will find more information about this study.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new study about severity of neurological Long-COVID symptoms and their correlation with the increased level of autoantibodies was published. In Table 1 you can have a look at the 200 individuals which were recruited and put into 3 groups. One group with 72 patients were diagnosed with Long-COVID, second group with 58 patients had&hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"yst_prominent_words":[910,445,847,175,641,950,948,446,1074,482,794],"class_list":["post-3372","post","type-post","status-publish","format-standard","hentry","category-news-en","category-9","description-off"],"_links":{"self":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/comments?post=3372"}],"version-history":[{"count":4,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3372\/revisions"}],"predecessor-version":[{"id":3386,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/posts\/3372\/revisions\/3386"}],"wp:attachment":[{"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/media?parent=3372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/categories?post=3372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/tags?post=3372"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.celltrend.de\/en\/wp-json\/wp\/v2\/yst_prominent_words?post=3372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}